Tirzepatide is the active in approved products such as Mounjaro and Zepbound. MEDVi has marketed compounded GLP-1s. The FDA’s 2026 letter to MEDVi is part of this answer.
Is MEDVi Tirzepatide Safe?
Nobody on a blog can certify a compounded lot you have not received. Approved pens have manufacturing and label controls compounded products do not automatically inherit. GLP-1 class effects include nausea, vomiting, and rarer serious risks described on approved labels. A clinician who knows your pancreatitis, thyroid, and GI history has to decide.
GLP-1 cluster · stopping GLP-1s · FDA letter
Sources Checked for This Page
- FDA warning letter MEDVi 721455 (20 February 2026) where GLP-1 claims are discussed.
- FDA labels for sildenafil, tadalafil, bremelanotide; FDA pages on compounding vs approval.
- Brand-facing MEDVi safety/pharmacy copy naming Belmar in GLP-1 materials, treated as company statements.
Individual ingredients such as sildenafil and tadalafil are FDA-approved for other indications; the combined compounded formulation has not been evaluated by the FDA as a finished product, standard for all compounded medicines. For product-level depth, use the flagship MEDVi QUAD review.